OZABIO at Vitafoods Europe 2025: Elevating Nutraceutical Performance on a Global Stage

OZABIO marked a powerful presence at Vitafoods Europe 2025, the world’s leading exhibition for nutraceutical innovation. As a global meeting point for scientific advancement, ingredient innovation, and market-leading brands, the event provided an exceptional platform to showcase the future of high-performance nutrition.

At the forefront of our presentation was LIPOZA, OZABIO’s advanced liposomal delivery platform—engineered to redefine how nutrients are absorbed, protected, and delivered. Our solutions attracted strong interest from international partners seeking next-generation formulations with superior bioavailability, enhanced stability, and measurable efficacy.

Global Engagement & Strategic Impact

Vitafoods Europe 2025 enabled OZABIO to:
● Build connections with key global stakeholders and decision-makers
● Showcase cutting-edge liposomal innovations to a highly specialized audience
● Explore collaborations across Europe, North America, and emerging markets
● Engage in high-level discussions on future trends, regulatory evolution, and consumer expectations

Our participation reinforced OZABIO’s position as a forward-thinking, innovation-driven partner for brands aiming to lead in a competitive global landscape.

Beyond Participation: Setting New Benchmarks

More than just an exhibition, Vitafoods Europe was a platform for OZABIO to demonstrate its commitment to scientific excellence and continuous innovation. By aligning our technology with global market needs, we continue to empower brands to create differentiated, high-impact nutraceutical products.

Get In Touch

Phone: +91 78769 66742, +1 (571)315-3939, +971 52 156 2603

Mail: [email protected]

Location: 1207 Delaware Ave #2877, Wilmington DE 19806, USA

© 2026 OzaBio | All Rights Reserved.

Dynamic Light Scattering (DLS) for particle size measurement

Dynamic Light Scattering (DLS) is employed to evaluate the particle size distribution and polydispersity of liposomal formulations, providing essential information on colloidal stability, dispersion uniformity, and potential bioavailability.
For example – Lipoza®-Curcumin

Zeta Potential Analysis for surface charge and stability

Zeta potential analysis provides insight into the surface charge and colloidal stability of liposomal formulations, where higher negative values indicate improved dispersion stability and reduced risk of particle aggregation.
For example – Lipoza®-VitC

Absorption and permeability through models like Caco-2 cell lines.

Caco-2 studies utilize human intestinal epithelial cell monolayers to evaluate the permeability and predicted absorption of test substances across the gut barrier.

For example – Lipoza-Glutathione
Demonstrated superior permeability, showing 0.95% transport compared to 0.29% for Reduced L-Glutathione—an approximate 3.28-fold increase. This enhanced permeability, despite lower glutathione content, indicates improved intestinal absorption and supports its potential as a more bioavailable form of glutathione supplementation.

1.TEM-Based Structural Analysis of Liposomal Formulations

Transmission Electron Microscopy (TEM) provides high-resolution visualization of liposomal morphology, enabling assessment of vesicle size, shape, and internal structure. Liposomes generally appear as well-defined spherical vesicles with a distinct bilayer and a darker core region.
For example – Lipoza®-Q10

2.SEM-Based Surface Characterization of Liposomes

Scanning Electron Microscopy (SEM) offers detailed visualization of surface morphology, enabling assessment of particle texture, external structure, and overall physical characteristics of liposomal powders. This technique helps confirm uniformity, surface smoothness, and morphological integrity of the formulation.
For example – Lipoza®-Fe
ozabio
Contact Form

Contact Information

Fill out the form below and we'll get back to you soon

Form submitted successfully! We'll contact you soon.
There was an error submitting the form. Please try again.

* indicates required question